drugset / Trial / NCT02304679

Low Energy Shockwave Therapy for Improving Erectile Dysfunction

NCT02304679

Completed 154 enrolled Nîmes University Hospital
RandomizedParallel-groupTriple-blindTreatment

Summary

The primary objective of this study is to evaluate the change from baseline in the erectile function domain of the International Index of Erectile Function (IIEF-EF) scores in patients receiving 4 weekly treatments of shockwave therapy versus those receiving a sham treatment. The change will be evaluated at 3 months after the end of a sequence of 4 weekly treatments.

Timeline

Start
2015-07-01
Primary completion
2018-02-21
Completion
2020-06-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Tadalafil Small molecule 5 mg

Indications